Price T Rowe Associates Inc Sellas Life Sciences Group, Inc. Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$5.36 - $9.53 $34,304 - $60,991	6,400 Added 59.81%	17,100 $95,000
Q3 2021 Nov 15, 2021	SELL	$8.21 - $10.53 $39,408 - $50,544	-4,800 Reduced 30.97%	10,700 $98,000
Q2 2021 Aug 16, 2021	SELL	$7.19 - $13.71 $83,404 - $159,036	-11,600 Reduced 42.8%	15,500 $172,000
Q1 2021 May 17, 2021	BUY	$5.5 - $11.71 $149,050 - $317,341	27,100 New	27,100 $231,000

4.37M

3.28M

56.3K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $24.7M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.